News
Alexis de Rosnay takes over responsibility for the ODDO BHF Group's Healthcare franchise and for the Group's project to establish a presence in the United Kingdom
Paris, September 2, 2021
Alexis de Rosnay, who joined ODDO BHF Group in September 2019 as Senior Advisor, is taking charge of the project to establish a subsidiary of the Franco-German group in the UK, for which he will be responsible. He will now also head ODDO BHF's Healthcare franchise.
The Franco-German group plans to develop and market some of its Private Wealth Management, Asset Management and Corporates & Markets services from London to UK and international clients based in the UK who may be interested in the Eurozone expertise and knowledge of the ODDO BHF teams.
Alexis de Rosnay's network, skills and extensive experience are essential assets to enable the Group to seize new opportunities in a market that remains deep and buoyant for the Group's businesses, and more particularly for the transversal development of the Health franchise.
In this capacity, as Head of the Group's Healthcare franchise and of the structure in the United Kingdom, once it is created*, Alexis de Rosnay will support all of the Group's teams working in the healthcare sector in the broadest sense of the term, in particular the Advisory, Equity Capital Market (ECM) and Private Equity teams.
Philippe Oddo, Managing Partner: "I am delighted to appoint Alexis de Rosnay as head of the Group's Healthcare franchise and to entrust him with the strategic mission of establishing the ODDO BHF Group on a long-term basis in the UK for all our businesses. Having lived in London for over 25 years and as a Franco-British national, Alexis de Rosnay is particularly well integrated in the London network. He will be our bridgehead to seize all the opportunities available to us on the UK market.”
About Alexis de Rosnay
Alexis started his career in M&A at Rothschild & Cie in 1990, and then joined J. P. Morgan in London in 1995, where he spent almost 10 years and was in particular responsible for the Healthcare franchise for
Europe. He then headed the Healthcare department at Lehman Brothers from 2004 to 2008, and then at Lazard from London, where he co-headed the office. In 2012, he became CEO of Canaccord Genuity Europe (Capital Markets & Wealth Management) and in 2015 Deputy CEO of Canaccord Genuity Group Inc. and Global Head of Investment Banking. In these roles, Alexis was involved in the M&A transactions leading to the creation of Novartis, Aventis, and various external growth transactions of Novartis, BioMérieux, Ipsen, GSK or Pfizer among others. He also led the IPOs of Almirall, Newron, Cosmo, Serono and Addex.
About ODDO BHF
ODDO BHF is an independent Franco-German financial services group, with a history stretching back over 170 years. It was created from the alliance of a French family-owned business built up by five generations of stockbrokers and a German bank specialising in Mittelstand companies. With 2,500 employees (1,300 in Germany and Switzerland and 1,200 in France and Tunisia), and more than 125 billion euros in assets under management, ODDO BHF operates in three main businesses, based on significant investment in market expertise: private banking, asset management and corporate and investment banking. The Group has a specific ownership structure as 65% of its capital is held by the Oddo family and 25 % by employees. This “partnership” ethos guarantees the long-term involvement of its teams. In 2020, ODDO BHF generated net banking income of 624 million euros, and at 31 December 2020, the Group had over 940 million euros of shareholders' equity.
www.oddo-bhf.com
Contacts
CITIGATE DEWE ROGERSON
Yoann Besse / Tom Ruvira
+33 1 53 32 78 89
+33 6 63 03 84 91
[email protected]
DGM
Hugues Schmitt / Christian d'Oléon
+33 1 40 70 11 89
+33 6 08 49 89 07
[email protected]
[email protected]
Our news
Equities remain unmatched over the long term
Three British economists—Paul Marsh and Mike Staunton of the London Business School, and Elroy Dimson from Cambridge University—have embarked on a meticulous endeavour: they have traced 35 stock markets around the world as far back as possible to test a core theoretical question of investment. Are equities truly superior to all other asset classes over the long term?
The moment of truth for public debt
Economic crises leave a legacy of high public debt. Expansion phases should be used as an opportunity by governments to reduce their debt and rebuild some headroom in their public finances. This is easier said than done. Let’s look at what happened after the last two major crises.
The end of the American dream?
We must confess that we have a strategic "bias" in favor of the US market. The past 15 years proves us quite right. Since the end of the 2007-2008 Financial Crisis, Europe has outperformed for only 27 months, or just over 2 years. This structural outperformance of the US vs. Europe is mainly explained by a more robust EPS dynamic in the US.